Toggle light / dark theme

Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions

– Results from the study continue to demonstrate the transformative potential of zimislecel with consistent and durable patient benefit – – All 12 patients with at least one year of follow-up who received a full dose of zimislecel as a single infusion achieved ADA –recommended target HbA1c levels…

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.